Why Anheuser-Busch Is Still a Buy Even Though People Are Drinking Less

Anheuser-Busch InBev reported Q1 2026 revenue growth of 5.8% year over year, while underlying EPS rose more than 20%. Growth was driven by premiumization, with no-alcohol beer sales up 27% and Beyond Beer sales up 37%. The article argues that declining global alcohol consumption remains a headwind, but AB InBev's product mix shift and 25% year-to-date stock gain support a constructive long-term view.

Analysis

The market is rewarding AB InBev not because beer demand is structurally healthy, but because management is proving it can grow mix faster than volumes deteriorate. That matters: in consumer staples, premiumization and adjacent categories typically support margins for longer than headline unit trends, so the equity can keep re-rating even if the category stays in secular decline. The key second-order effect is that weaker mainstream volume should continue to force rationalization across smaller brewers and distributors, widening the gap between scaled global platforms and local/regional players.

The real setup is that investors may be underestimating the durability of pricing power in an “elasticity-lite” category. If no-alcohol and beyond-beer remain the growth engine, AB InBev is less a beer-volume story and more a branded beverage compounder, which reduces downside sensitivity to the consumption data cited in the article. That creates a favorable asymmetry over the next 6–12 months: modest volume pressure can be offset by mix, but a reversal would likely require either an abrupt consumer downshift or evidence that premium trade-up is saturating.

Constellation is the more interesting relative winner if the market rotates from “defensive staples” to “premium growth with alcohol exposure.” The trade is not about who sells more liquid, but who controls the highest-velocity brand architecture and can preserve pricing without collapsing velocity. The contrarian miss is that the broader category contraction may actually be accretive for the strongest incumbents, since fewer weak players means less promotional intensity and better shelf economics.

Key Decisions for Investors

• Stay long BUD on a 6-12 month horizon; best entry is on any 3-5% pullback because the setup is mix-led rather than volume-led and should hold unless premiumization decelerates sharply.
• Add STZ as a relative-value long vs. broad consumer staples for the next 3-6 months; it is the cleaner way to express premium beverage resilience if the market keeps rewarding brand-led pricing power.
• Pair trade: long BUD / short a basket of smaller alcohol or lower-quality consumer beverage names for 3-6 months; thesis is margin share gains as promotional pressure eases and weaker competitors lose shelf space.
• Sell near-dated downside puts on BUD only if implied vol remains elevated; the earnings/margin floor is better than the headline category narrative suggests, so premium capture is attractive if you can tolerate drawdown risk.